Related Experiment Video
Updated: Jul 15, 2025

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
Published on: September 13, 2022
Is it Safe to Continue Aspirin in Patients Undergoing Percutaneous Nephrolithotomy?
Shree Agrawal-Patel1, Harmenjit Brar1, Marlie Elia2
1Cleveland Clinic, Glickman Urological and Kidney Institute, Cleveland, OH.
Continuing aspirin therapy during percutaneous nephrolithotomy (PCNL) did not increase postoperative complications. However, patients on additional anticoagulation medication face a higher risk of hematologic complications during PCNL.
Area of Science:
- Nephrology and Urology
- Cardiovascular Medicine
- Surgical Outcomes
Background:
- American Urological Association guidelines contraindicate anticoagulation and anti-platelet therapy for PCNL due to bleeding risks.
- Discontinuing aspirin peri-procedurally may increase cardiovascular risks for patients on chronic aspirin therapy.
- Evaluating peri-operative outcomes in patients undergoing PCNL with and without aspirin discontinuation is crucial.
Purpose of the Study:
- To assess peri-operative outcomes in patients undergoing percutaneous nephrolithotomy (PCNL) while on chronic aspirin therapy.
- To compare outcomes between patients who continued aspirin and those who discontinued it preoperatively.
- To identify risk factors associated with complications during PCNL in patients on aspirin therapy.
Main Methods:
- Retrospective review of 325 patients on chronic aspirin therapy undergoing PCNL between January 2014 and May 2019.
- Stratification of patients into two groups: continued aspirin and discontinued aspirin (>5 days preoperatively).
- Assessment of hematologic, transfusions, and thrombotic complications using logistic regression.
Main Results:
- No significant differences in hemoglobin change, estimated blood loss, transfusions, creatinine change, thrombotic complications, re-admissions, or emergency department visits between groups.
- Patients who continued aspirin had a slightly longer length of stay (1.9 vs 1.6 days, P=.03).
- Higher American Society of Anesthesiologists (ASA) scores, Black race, and previous smoking were associated with continued aspirin use; BMI ≥30 was associated with discontinuation.
- Additional anticoagulation medication increased the risk of postoperative hematologic complications (OR 2.9, P=.04).
Conclusions:
- Continued aspirin use is not associated with an increase in postoperative complications for patients undergoing PCNL.
- Patients requiring additional anticoagulation medication alongside aspirin are at a higher risk for hematologic complications.
- The findings suggest a need to re-evaluate aspirin discontinuation protocols for PCNL in select patient populations.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Cardiac Catheterization IV: Nursing Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Calculi VI: Surgical Management
Aneurysm IV: Nursing Management

